Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-25-000529
Filing Date
2025-02-18
Accepted
2025-02-18 17:50:26
Documents
1
Period of Report
2025-02-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312927027_02182025.html 3  
1 OWNERSHIP DOCUMENT form312927027_02182025.xml 3 2151
  Complete submission text file 0000921895-25-000529.txt   3670
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Issuer) CIK: 0001540159 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 NORTH MAIN STREET SUITE 301 ALPHARETTA GA 30009
Business Address
Liu Da David (Reporting) CIK: 0002054265 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37619 | Film No.: 25636425